NO20000241L - Trisykliske vasopressin agonister - Google Patents

Trisykliske vasopressin agonister

Info

Publication number
NO20000241L
NO20000241L NO20000241A NO20000241A NO20000241L NO 20000241 L NO20000241 L NO 20000241L NO 20000241 A NO20000241 A NO 20000241A NO 20000241 A NO20000241 A NO 20000241A NO 20000241 L NO20000241 L NO 20000241L
Authority
NO
Norway
Prior art keywords
tricyclic
vasopressin agonists
disorders
agonists
compounds
Prior art date
Application number
NO20000241A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000241D0 (no
Inventor
Amedeo Arturo Failli
Jay Scott Shumsky
Robert John Steffan
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of NO20000241D0 publication Critical patent/NO20000241D0/no
Publication of NO20000241L publication Critical patent/NO20000241L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20000241A 1997-07-30 2000-01-18 Trisykliske vasopressin agonister NO20000241L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90337097A 1997-07-30 1997-07-30
US94170797A 1997-07-30 1997-07-30
PCT/US1998/015487 WO1999006403A1 (en) 1997-07-30 1998-07-24 Tricyclic vasopressin agonists

Publications (2)

Publication Number Publication Date
NO20000241D0 NO20000241D0 (no) 2000-01-18
NO20000241L true NO20000241L (no) 2000-03-06

Family

ID=27129361

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000241A NO20000241L (no) 1997-07-30 2000-01-18 Trisykliske vasopressin agonister

Country Status (17)

Country Link
EP (1) EP1000059B1 (hu)
JP (1) JP2001512120A (hu)
KR (1) KR20010022397A (hu)
CN (1) CN1162429C (hu)
AT (1) ATE277926T1 (hu)
AU (1) AU8592598A (hu)
BR (1) BR9811559A (hu)
CA (1) CA2297407A1 (hu)
DE (1) DE69826677T2 (hu)
DK (1) DK1000059T3 (hu)
ES (1) ES2229523T3 (hu)
HU (1) HUP0003394A3 (hu)
IL (1) IL133787A0 (hu)
NO (1) NO20000241L (hu)
NZ (1) NZ502448A (hu)
PT (1) PT1000059E (hu)
WO (1) WO1999006403A1 (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60001054T2 (de) * 1999-02-04 2003-07-24 Wyeth Corp Trizyclische pyridin n-oxide vasopressin agonisten
AU2849600A (en) * 1999-02-04 2000-08-25 American Home Products Corporation Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
GB0000079D0 (en) * 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
GB0015601D0 (en) * 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
PL362835A1 (en) 2000-12-01 2004-11-02 Ajinomoto Co,Inc. Lactam compounds and medicinal use thereof
EP1619185B1 (en) 2003-04-28 2011-06-15 Astellas Pharma Inc. 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof
GB201005623D0 (en) 2010-04-01 2010-05-19 Vantia Ltd New polymorph
TW201444798A (zh) 2013-02-28 2014-12-01 必治妥美雅史谷比公司 作爲強效rock1及rock2抑制劑之苯基吡唑衍生物
US9828345B2 (en) 2013-02-28 2017-11-28 Bristol-Myers Squibb Company Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1251767B (de) * 1964-02-28 1968-04-18 Dr Karl Thomae Gesellschaft mit beschrankter Haftung Biberach/Riß Verfahren zur Herstellung von neuen m 6 Stellung substituierten 5 6 Dihydro-5oxo HH pyrido[2,3-b] [l,5]benzodiazepinen
US5512563A (en) * 1993-07-29 1996-04-30 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
US5420270A (en) * 1993-10-07 1995-05-30 G. D. Searle & Co. Aryl substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
AR002459A1 (es) * 1995-01-17 1998-03-25 American Cyanamid Co Antagonistas de vasopresina de benzacepina triciclicos, una composicion farmaceutica que los contiene, un metodo para tratar enfermedades y unprocedimiento para su preparacion.
TW359669B (en) * 1995-12-15 1999-06-01 Otsuka Pharma Co Ltd Benzazepine derivatives

Also Published As

Publication number Publication date
HUP0003394A2 (hu) 2001-08-28
CA2297407A1 (en) 1999-02-11
WO1999006403A1 (en) 1999-02-11
CN1162429C (zh) 2004-08-18
NO20000241D0 (no) 2000-01-18
JP2001512120A (ja) 2001-08-21
CN1272110A (zh) 2000-11-01
HUP0003394A3 (en) 2003-04-28
EP1000059A1 (en) 2000-05-17
ATE277926T1 (de) 2004-10-15
DK1000059T3 (da) 2005-01-10
EP1000059B1 (en) 2004-09-29
BR9811559A (pt) 2000-09-12
DE69826677D1 (de) 2004-11-04
ES2229523T3 (es) 2005-04-16
PT1000059E (pt) 2004-12-31
NZ502448A (en) 2002-12-20
IL133787A0 (en) 2001-04-30
AU8592598A (en) 1999-02-22
KR20010022397A (ko) 2001-03-15
DE69826677T2 (de) 2005-02-10

Similar Documents

Publication Publication Date Title
EA200300713A1 (ru) Производные бензимидазола и пиридилимидазола в качестве лигандов рецепторов гамма-аминомасляной кислоты
WO2005072308A3 (en) Cgrp receptor antagonists
EA200500453A1 (ru) Имидазопиридины и способы их получения и применения
EP2269610A3 (en) Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
WO2001081310A8 (en) 1-aroyl-piperidinyl benzamidines
MA25809A1 (fr) Derives d'arylmethylamine pour usage comme inhibiteurs de tryptase
EA200200208A1 (ru) Синергитическая композиция
EA200201214A1 (ru) Замещенные тиоацетамиды
WO2006104870A3 (en) Methods of treating benign prostatic hyperplasia or lower urinary track symptoms by using pde 5 inhibitors
NO20000241L (no) Trisykliske vasopressin agonister
EA199900542A1 (ru) Соединения сульфоновой кислоты или сульфониламино-n-(гетероаралкил)-азагетероциклиламида
ATE304523T1 (de) Trisubstituierte-n-((1s)-1,2,3,4-tetrahydro-1- naphthalenyl) benzamide welche p2x3 und p2x2/3 enthaltende rezeptoren inhibieren
BR9910899A (pt) Compostos de ácido sulfÈnico ou sulfonilamino n-(hetero-aralquil)-azaeterocicliamida
DK1276476T3 (da) Anvendelse af bradykardiske midler ved behandling af sygdomme i hjertemuskulaturen i forbindelse med hypertrofi, samt hedtil ukendte lægemiddelkombinationer
NO20005883L (no) Anvendelse av <alfa>1<beta>1-integrinreseptorinhibitorer og TGF-<beta>1-inhibitorer i behandling av nyresykdom
DE60326263D1 (de) Pyrimidin-sulfonamide und ihre verwendung als endothelin-rezeptor-antagonisten
ATE295183T1 (de) Mittel zur linderung von juckreiz, enthaltend pgd2- antagonisten
WO2000046224A3 (en) Tricyclic pyridine n-oxides vasopressin agonists
EA200401137A1 (ru) Фармацевтическая композиция, содержащая ингибитор pde4 или pde3/4 и антагонист гистаминового рецептора
ATE375346T1 (de) Cyclohexylphenyl vasopressin agonisten
WO2000046225A3 (en) Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
DE60213361D1 (de) Flüssige antimikrobielle zusammensetzungen
DE60036568D1 (de) N-acylpyrrolidin-2-ylalkylbenzamidin-derivate als inhibitoren von factor xa
ATE294790T1 (de) Chlormethylierung von thiophene
DE60227113D1 (de) Kondensierte camptothecine als antitumormittel

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application